secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longevity Health Holdings, Inc. (XAGE)
CIK:        0001842939
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0000950170-25-035950
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Carmell rebrands to Longevity Health (XAGE); guides FY25 rev $3-4M; names Vice Chairman
--------------------------------------------------------------------------------

- Name change to Longevity Health Holdings effective March 5; tickers to XAGE/XAGEW March 10.
- Patrick Sturgeon appointed Vice Chairman; previously CFO and board director since July 2023.
- Combined sales grew 34% in Jan-Feb 2025 vs 2024 post Elevai acquisition.
- Elevai's post-acquisition burn rate reduced >50% via overhead cost synergies.
- FY25 revenue guidance $3-4M; Q2 2025 product launches include hair growth serum, soapless facial cleanser, etc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842939/000095017025035950/0000950170-25-035950-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842939/000095017025035950/ctcx-20250305.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-035950

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer